Publications by authors named "Jim P Doherty"

Claim this Profile
R
Real-world treatment patterns in patients with advanced (stage III-IV) ovarian cancer in the USA and Europe.
Jennifer P Hall, Jane Chang, Rebecca Moon, Olivia Higson, Katherine Byrne, Jim P Doherty

Future Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns and Health Outcomes in Platinum-Refractory or Platinum-Resistant Ovarian Cancer: A Retrospective Medical Record Review.
Rohan Parikh, Samantha K Kurosky, Margarita Udall, Jane Chang, Joseph C Cappelleri, Jim P Doherty

Int J Gynecol Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042).
Dong-Wan Kim, Edward B Garon, Aminah Jatoi, Dorothy M Keefe, Mario E Lacouture, Jim P Doherty

Lung Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial.
Suresh S Ramalingam, Pasi A Jänne, Tony Mok, Kenneth O'Byrne, Michael J Boyer, Jim P Doherty

Lancet Oncol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis